According to a new study, current evidence suggests that stopping antiplatelet or anticoagulant therapy before simple dental ...

The use of antiplatelet and/or anticoagulant medications has increased due to irregular diets, limited physical activity, and ...

Health-related social needs in HF, removing age from frailty scores, CIED concerns about smartwatches, and more.

Replacing aspirin with a P2Y12 inhibitor soon after coronary stenting is tied to a higher ischemic risk than dual antiplatelet therapy in the first 30 days, but not later, in acute coronary syndrome.

NRoute launches Heartisafe, a science-backed supplement for heart health, featuring patented Fruitflow extract and EFSA-approved benefits.

Results published in Journal of Vascular Surgery Cases, Innovations and Techniques (JVS-CIT) - - After up to 36 months of follow-up, patients ...

The ZENITH trial showed sotatercept significantly reduced death, transplant, or hospitalization risk in advanced PAH, leading ...

NRoute, a leading health and fitness supplement company, announced on Monday the launch of its latest innovation, Heartisafe. Designed to enhance cardiovascular health, Heartisafe is a potent ...

NRoute launches Heartisafe, a supplement enhancing cardiovascular health by improving blood flow with natural bioactive compounds.

In patients with diabetes and multivessel coronary artery disease undergoing percutaneous coronary intervention, ticagrelor ...

A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.

"Patients with cancer-associated thrombosis are both at risk of recurrent venous thromboembolism and bleeding during extended ...